38 CHAPTER 1 18. Scheffer AR, Erasmus C, van Hulst K, van Limbeek J, Jongerius PH, van den Hoogen FJ. Efficacy and duration of botulinum toxin treatment for drooling in 131 children. Arch Otolaryngol Head Neck Surg 2010; 136: 873–7. 19. Twisk J, de Boer M, de VenteW, Heymans M. Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis. J Clin Epidemiol 2013; 66: 1022–8. 20. Yildirim YSS, Kaygusuz I, Ozercan IH, et al. Histopathological changes in parotid gland following submandibular gland failure: an experimental animal study. Braz J Otorhinolaryngol 2019; 85: 422–6. 21. Berweck S, Schroeder AS, Lee SH, Bigalke H, Heinen F. Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands. Dev Med Child Neurol 2007; 49: 62–4. 22. Wilken B, Aslami B, Backes H. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Neuropediatrics 2008; 39: 200–4. 23. Moller E, Daugaard D, Holm O, et al. Repeated treatments of drooling with botulinum toxin B in neurology. Acta Neurol Scand 2015; 131: 51–7. 24. Kahraman A, Seyhan K, Deger U, Kutluturk S, Mutlu A. Should botulinum toxin A injections be repeated in children with cerebral palsy? A systematic review. Dev Med Child Neurol 2016; 58: 910–7. 25. Ahn C, Kang S, Sa HS. Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment. Eye (Lond) 2019; 33: 995–9. 26. Berthin C, Maillard H. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a 15-year study in 117 patients. Acta Derm Venereol 2019; 99: 1237–40. 27. Berman B, Seeberger L, Kumar R. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia. Mov Disord 2005; 20: 233–7. 28. Fattal-Valevski A, Domenievitz D, Giladi N, Wientroub S, Hayek S. Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: a prospective study. J Child Orthop 2008; 2: 29–35. 29. van Hulst K, Kouwenberg CV, Jongerius PH, et al. Negative effects of submandibular botulinum neurotoxin A injections on oral motor function in children with drooling due to central nervous system disorders. Dev Med Child Neurol 2017; 59: 531–7. 30. Van Hulst K, Van Der Burg JJW, Jongerius PH, Geurts ACH, Erasmus CE. Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities. Dev Med Child Neurol 2020; 62: 354–62.
RkJQdWJsaXNoZXIy MjY0ODMw